Author:
Liu Tong-Yu,Xie Rong,Luo Li,Reilly Kathleen H.,He Cheng,Lin Yu-Zhen,Chen Gang,Zheng Xiong-Wei,Zhang Lu-Lu,Wang Hai-Bo
Reference32 articles.
1. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme;Anttila;Br. Med. J.,2010
2. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test;Benevolo;J. Clin. Microbiol.,2011
3. Diagnostic and prognostic validity of the human papillomavirus E6/E7 mRNA test in cervical cytological samples of HC2-positive patients;Benevolo;Cancer Causes Control,2011
4. Detection of human papillomavirus E6/E7 mRNA in women with high-risk HPV types 16, 18, 31, 33 and 45 which are associated with the development of human cervical cancer;Bertuccio;Eur. J. Gynaecol. Oncol.,2011
5. A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer;Castle;Clin. Cancer Res.,2007